Cerenome, Inc.
CNSY
$2.49
-$0.21-7.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 411.00K | 1.03M | 1.37M | 1.40M | 1.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 411.00K | 1.03M | 1.37M | 1.40M | 1.39M |
| Cost of Revenue | 4.27M | 2.87M | 2.94M | 2.44M | 1.25M |
| Gross Profit | -3.85M | -1.84M | -1.57M | -1.04M | 144.00K |
| SG&A Expenses | 5.20M | 5.28M | 4.17M | 3.44M | 1.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.47M | 8.15M | 7.11M | 5.88M | 2.93M |
| Operating Income | -9.06M | -7.12M | -5.74M | -4.48M | -1.54M |
| Income Before Tax | -9.01M | -6.95M | -5.71M | -4.42M | 5.15M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.01M | -6.95M | -5.71M | -4.42M | 5.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.01M | -6.95M | -5.71M | -4.42M | 5.15M |
| EBIT | -9.06M | -7.12M | -5.74M | -4.48M | -1.54M |
| EBITDA | -8.92M | -7.02M | -5.60M | -4.41M | -1.46M |
| EPS Basic | -1.31 | -1.05 | -1.04 | -1.03 | 0.62 |
| Normalized Basic EPS | -0.82 | -0.65 | -0.65 | -0.64 | 1.66 |
| EPS Diluted | -1.31 | -1.05 | -1.05 | -1.03 | -0.16 |
| Normalized Diluted EPS | -0.82 | -0.65 | -0.65 | -0.64 | 0.38 |
| Average Basic Shares Outstanding | 6.90M | 6.65M | 5.51M | 4.30M | 1.94M |
| Average Diluted Shares Outstanding | 6.90M | 6.65M | 5.51M | 4.30M | 8.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |